Proteinuria as a surrogate end point—more data are needed

Enrichment of Clinical Study Populations

(2010) R Temple   CLINICAL PHARMACOLOGY & THERAPEUTICS

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

(2010) George L Bakris et al.   LANCET

Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration

(2009) Andrew S. Levey et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

(2009) Marc A. Pfeffer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

The Normal Hematocrit Study — Follow-up

(2008) Anatole Besarab et al.   NEW ENGLAND JOURNAL OF MEDICINE